Burrill & Company

North America, California, United States, San Francisco

Description

Burrill & Company is a venture capital and private equity firm that invests in life sciences, biotechnology, and healthcare companies.

Investor Profile

Burrill & Company has backed more than 94 startups, with 0 new investments in the last 12 months alone. The firm has led 18 rounds, about 19% of its total and boasts 27 exits across its portfolio.

Investment Focus Highlights

Concentrates on Series B, Series A, Series Unknown rounds (top funding stages).
Majority of deals are located in United States, United Arab Emirates, India.
Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

Series B (29%)
Series A (19%)
Series Unknown (17%)
Series C (13%)
Series D (10%)
Post Ipo Equity (5%)
Series E (2%)
Debt Financing (1%)
Private Equity (1%)
Series F (1%)

Country Focus

United States (96%)
United Arab Emirates (2%)
India (1%)
China (1%)

Industry Focus

Biotechnology
Health Care
Medical
Pharmaceutical
Medical Device
Biopharma
Life Science
Therapeutics
Health Diagnostics
Wellness

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Burrill & Company frequently co-invest with?

Perseus-Soros Biopharmaceutical Fund

North America, New York, United States, New York

Co-Investments: 4

HealthCare Ventures

North America, Massachusetts, United States, Cambridge

Co-Investments: 5

MPM Capital

North America, Massachusetts, United States, Boston

Co-Investments: 6

Prolog Ventures

North America, Missouri, United States, St Louis

Co-Investments: 9

Novo Holdings

Europe, Hovedstaden, Denmark, Hellerup

Co-Investments: 6

Biomark Capital

North America, Connecticut, United States, Greenwich

Co-Investments: 4

Alta Partners

North America, Mississippi, United States, Jackson

Co-Investments: 4

Morgenthaler Ventures

North America, California, United States, Menlo Park

Co-Investments: 6

Great Spirit Ventures

North America, California, United States, Mill Valley

Co-Investments: 7

Khosla Ventures

North America, California, United States, Menlo Park

Co-Investments: 6

Which angels does Burrill & Company often collaborate with?

Alejandro Zaffaroni

North America, California, United States, Mountain View

Shared Deals: 1

James Tullis

North America, Florida, United States, West Palm Beach

Shared Deals: 1

What are some of recent deals done by Burrill & Company?

Neos Therapeutics

Grand Prairie, Texas, United States

Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.

BiotechnologyLife ScienceMedicalTherapeutics

Series UnknownFeb 19, 2015

Amount Raised: $20,624,355

Nora Therapeutics

Palo Alto, California, United States

Nora Therapeutics is a specialty biopharmaceutical company developing therapeutics to address clinical unmet needs in reproductive medicine.

BiotechnologyHealth CareMedical Device

Series BApr 17, 2014

Amount Raised: $18,000,000

Neos Therapeutics

Grand Prairie, Texas, United States

Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.

BiotechnologyLife ScienceMedicalTherapeutics

Series CMar 4, 2014

Amount Raised: $15,500,000

BetterDoctor

San Francisco, California, United States

BetterDoctor, a technology company, delivers provider directory data and has a database that can be accessed through a responsive API.

AppsDatabaseDeveloper APIsHealth CareInternetMedicalMobileSearch Engine

SeedOct 22, 2013

Amount Raised: $2,600,000

NewBridge Pharmaceuticals

Dubai, Dubai, United Arab Emirates

Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.

BiotechnologyMedical DeviceOncologyPharmaceutical

Series CMay 29, 2013

Amount Raised: $48,000,000

Catalyst Biosciences

South San Francisco, California, United States

Catalyst Biosciences is a biopharmaceutical company that offers protease therapeutics to address disorders of the coagulation system.

BiopharmaBiotechnologyLife SciencePharmaceutical

Post Ipo EquityApr 1, 2013

Amount Raised: $5,072,000

Odyssey Thera

San Ramon, California, United States

Odyssey Thera develops cellular pharmacology strategy for the identification of medicines for cancer and other human diseases.

BiopharmaBiotechnologyHealth CarePharmaceutical

Series UnknownFeb 14, 2013

Amount Raised: $2,800,000

Strand Life Sciences

Bangalore, Karnataka, India

Strand is leading a new generation of healthcare defined by genetic insights into disease.

BioinformaticsBiotechnologyGeneticsHealth CareInformation TechnologyMedical

Series BFeb 14, 2013

MabVax Therapeutics

San Diego, California, United States

MabVax is a biopharmaceutical company focused on the commercialization of proprietary anti-cancer immunotherapies.

BiotechnologyMedicalPharmaceutical

Series BNov 20, 2012

Amount Raised: $5,250,000

Cobalt Technologies

Mountain View, California, United States

Cobalt Technologies develops technologies that focuses and designed for biofuels.

BiofuelBiotechnologyCleanTech

Series UnknownOct 1, 2012

Amount Raised: $4,977,000

Burrill & Company

Description

Investor Profile

Investment Focus Highlights

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Burrill & Company frequently co-invest with?

Which angels does Burrill & Company often collaborate with?

What are some of recent deals done by Burrill & Company?

Ready to Raise Capital?

Pages

Free tools